The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients

Jason A Trubiano1, Vivian Leung1, Man Yee Chu1, Leon J Worth1, Monica A Slavin1, Karin Thursky2
1Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia
2Victorian Infectious Diseases Service, Peter Doherty Institute, Melbourne, Australia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensitivity reactions to beta lactams. Allergy. 2009;64:183–93.

Romano A, Warrington R. Antibiotic allergy. Immunol Allergy Clin North Am. 2014;34(3):489–506.

Trubiano J, Phillips E. Antimicrobial stewardship’s new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’. Curr Opin Infect Dis. 2013;26(6):526–37.

Charneski L, Deshpande G, Smith SW. Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients. Pharmacotherapy. 2011;31(8):742–7.

Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study. J Allergy Clin Immunol. 2014;133(3):790–6.

Charlson ME, Ales KL, Simon R, MacKenzie CR. Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med. 1987;147(12):2155–61.

Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2014.

Tam CS, O’Reilly MO, Andresen D, Lingaratnam S, Kelly A, Burbury K, et al. Use of empiric antimicrobial therapy in neutropenic fever. Intern Med J. 2011;41:90–101.

Trubiano J, Worth L, Thursky K, Slavin M. The prevention and management of infections due to multi-drug-resistant organisms in haematology patients. Br J Clin Pharmacol. 2015;79(2):195–207.

Lingaratnam S, Thursky KA, Slavin MA. Fluoroquinolone prophylaxis: a word of caution. Leuk Lymphoma. 2011;52(1):5–6.

Haeusler GM, Slavin MA. Fluoroquinolone prophylaxis: worth the cost? Leuk Lymphoma. 2013;54(4):677–8.

Bourke J, Hollingsworth PR, McLean-Tooke P, Phillips E. Penicillin de-labelling in tertiary care clinics: safe and efficacious but incomplete effectiveness. Int Med J. 2012;42(Supplement 4):21–2.

Chovel-Sella A, Ben Tov A, Lahav E, Mor O, Rudich H, Paret G, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013;131(5):e1424–7.

Romano A, Demoly P. Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol. 2007;7(4):299–303.

Rive CM, Bourke J, Phillips EJ. Testing for drug hypersensitivity syndromes. Clin Biochem Rev. 2013;34(1):15–38.